SGLT2 Inhibitors and the Risk of Hospitalization for Fournier’s Gangrene: A Nested Case–Control Study

被引：0
|
作者：
Tongtong Wang
Shrita M. Patel
Anne Hickman
Xinyue Liu
Philip LStJ Jones
Ira Gantz
Carol E. Koro
机构：
[1] Merck & Co.,Department of Pharmacoepidemiology
[2] Inc.,Department of Clinical Safety and Risk Management
[3] Merck & Co.,Department of Global Clinical Development
[4] Inc.,Pharmaceutical Health Services Research, School of Pharmacy
[5] Safety Surveillance and Risk Management,undefined
[6] Pfizer Inc.,undefined
[7] Safety Surveillance and Risk Management,undefined
[8] Pfizer Inc.,undefined
[9] Merck & Co.,undefined
[10] Inc.,undefined
[11] University of Maryland,undefined
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
Antihyperglycemic agents; Fournier’s gangrene; Nested case–control study; Sodium–glucose cotransporter 2 inhibitors (SGLT2i); Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：711 / 723
页数：12
相关论文
共 50 条
  • [41] Health Canada: risk of acute pancreatitis with SGLT2 inhibitors
    Reactions Weekly, 2018, 1713 (1) : 1 - 1
  • [42] SGLT2 inhibitors as standard medication for at-risk patients
    Fehner, G.
    Schmidt, K-R
    DIABETOLOGE, 2018, 14 (02): : 96 - 98
  • [43] Case study: Fournier's gangrene: management of an extensive wound
    Gibbins, S.
    WOUND PRACTICE AND RESEARCH, 2006, 14 (03): : 112 - 115
  • [44] Risk of acute kidney injury with two SGLT2 inhibitors
    Reactions Weekly, 2015, 1575 (1) : 6 - 6
  • [45] SGLT2 Inhibitors and Mortality Risk in Individuals with Advanced CKD
    Issa, Rochell
    Dobre, Mirela A.
    Makhlouf, Mohamed
    Negrea, Lavinia Aura
    Brateanu, Andrei
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [46] Norepinephrine/VasopressinScrotal Fournier's gangrene: 2 case reports
    Reactions Weekly, 2025, 2047 (1) : 355 - 355
  • [47] Organ protection beyond glycaemic control with SGLT2 inhibitors
    Panchapakesan, Usha
    Pollock, Carol
    NATURE REVIEWS NEPHROLOGY, 2021, 17 (04) : 223 - 224
  • [48] SGLT2 inhibitors: new kids on the block to control hyperkalemia
    Gabai, Pierre
    Fouque, Denis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (06) : 1345 - 1348
  • [49] Organ protection beyond glycaemic control with SGLT2 inhibitors
    Usha Panchapakesan
    Carol Pollock
    Nature Reviews Nephrology, 2021, 17 : 223 - 224
  • [50] A case series of diabetic ketoacidosis associated with SGLT2 inhibitors
    Zac-Varghese, Sagen
    Mathew, Sunitha
    Go, Daniel
    Winocour, Peter
    PRACTICAL DIABETES, 2023, 40 (03) : 21 - +
12345